SecBot SecBot
8-K ·Filed May 11, 2026

CRON

Cronos Group Inc.
BULLISH
Impact 7/10
Horizonweeks Processed5mo ago SEC0001656472-26-000032
8-K material event: Items 1.01
Actionable Insight ▲ Bullish

Strong Q1 results with accelerating revenue growth and profitability, plus a $822M cash position, make CRON a standout in the cannabis sector. Monitor the CanAdelaar closing timeline (now Sept 9) as a catalyst for European expansion. The $50M buyback provides downside support.

DirectionBullish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
CRON ▼ -1.09% at T+60d
LONG call ✗ call lost -1.09% · α vs SPY -5.48% · entry $2.75 → $2.72
Entry = T+0 close
May 11, 2026
via day close
T+1d
+0.73%
call +0.73% · α +0.86%
$2.77
settled 6mo ago
T+5d
-4.73%
call -4.73% · α -4.64%
$2.62
settled 5mo ago
T+20d
+1.45%
call +1.45% · α +1.76%
$2.79
settled 5mo ago
T+60d
-1.09%
call -1.09% · α -5.48%
$2.72
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Cronos Group reported strong Q1 2026 results with net revenue up 40% YoY to $45.2M and net income more than doubling to $15.7M, driven by record cannabis flower sales in Israel and international markets. The company also extended the closing date for its CanAdelaar acquisition to September 9, 2026, and announced a new $50M share repurchase program. The combination of accelerating revenue growth, expanding profitability, and a $822M cash-rich balance sheet supports a bullish outlook.

Key Financial Metrics

EPS
$0.04
est $0.01 · +300.0%
Revenue
$45.2M
est $57.6M · -21.5% · +40.0% YoY
Rating
strong beat
Free Cash Flow
$9.1M
Gross Margin
42%
Deal Value
$67.0M
Deal Type
acquisition

Key Facts

  • Q1 2026 net revenue of $45.2M, up 40% YoY from $32.3M
  • Net income of $15.7M, up 103% YoY from $7.7M
  • Adjusted EBITDA of $5.1M, up 122% YoY from $2.3M
  • Israel net revenue grew 53% YoY; international markets outside Israel grew 97% YoY
  • Cash and cash equivalents of $821.9M as of March 31, 2026
  • CanAdelaar acquisition long-stop date extended to September 9, 2026
  • New $50M share repurchase program authorized, succeeding prior program
  • Repurchased 13.4M shares for ~$33.5M under prior program

Financial Impact

Revenue growth of 40% YoY to $45.2M, net income doubled to $15.7M, Adjusted EBITDA up 122% to $5.1M

revenuenet incomeadjusted EBITDAcash

Risk Factors

  • CanAdelaar acquisition may face further regulatory delays or fail to close
  • Anti-dumping investigation in Israel could disrupt key market
  • Middle East conflict could impact Israel operations
  • Operating expenses rising 18% YoY may pressure margins if revenue growth slows

Market Snapshot

Exchange
Nasdaq
Sector
Medicinal Chemicals & Botanical Products
Analyst Consensus
89% bullish (9 analysts)

Investment Themes

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001656472-26-000032
Exhibit: exhibit-canadelaarspaamend.htm0001656472-26-000032
Document: cron-20260508.htm0001656472-26-000032
Document: 0001656472-26-000032-index-headers.html0001656472-26-000032
Document: 0001656472-26-000032-index.html0001656472-26-000032
Document: 0001656472-26-000032.txt0001656472-26-000032
8-K Data (Synthetic)0001656472-26-000032
9 reports for CRON
Performance horizon
75% Hit rate @ T+1 3 of 4 directional calls Went positive at some point 4 of 4 best @ T+5▲ +7.66%Oct 15, 2026
Filters
Rows
Reports for CRON — sortable, filterable
TypeNow
Oct 15, 2026
12d ago
8-K
BULLISH ★ 6/10
$3.20 $3.21▲ +0.31%▲ +1.42%$3.38 (+5.78%)
Oct 15, 2026
12d ago
Press Release
BULLISH ★ 6/10
$3.20 $3.21▲ +0.31%▲ +1.42%$3.38 (+5.78%)
Aug 6, 2026
11w ago
8-K
BULLISH ★ 7/10
$3.07 $3.10▲ +0.98%▲ +0.37%$3.38 (+10.26%)
Aug 6, 2026
11w ago
Press Release
MIXED ★ 6/10
$3.07 $3.10▲ +0.98%▲ +0.37%$3.38 (+10.26%)
Jul 16, 2026
14w ago
Press Release
NEUTRAL ★ 1/10
$2.75awaiting T+1—$3.38 (+23.09%)
Jun 16, 2026
18w ago
Press Release
NEUTRAL ★ 3/10
$2.67 $2.71▲ +1.50%▲ +0.72%$3.38 (+26.78%)
May 11, 2026
24w ago
8-K
BULLISH ★ 7/10
$2.75 $2.77▲ +0.73%▲ +0.86%$3.38 (+23.09%)
Apr 20, 2026
27w ago
Press Release
NEUTRAL ★ 1/10
$2.76awaiting T+1—$3.38 (+22.64%)
Feb 26, 2026
34w ago
8-K
BULLISH ★ 8/10
$2.67 $2.67· 0.00%▲ +0.45%$3.38 (+26.78%)
Showing 9 of 9

US Market Status

Market Open — Closes in 1m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 11, 2026